Drug induced Kounis syndrome: does oxidative stress play a role?

• Main Authors: Luisa Ricciardi, Fabiana Furci, Marco Casciaro, Eleonora Di Salvo, Mariateresa Cristani, Valeria Tigano, Paola Lucia Minciullo, Sebastiano Gangemi
• Format: Article
• Language: English
• Published: BMC 2018-10-01
• Series: Clinical and Molecular Allergy
• Subjects: Kounis syndrome; Cardiac anaphylaxis; Drug allergy; Oxidative stress; Advanced oxidation protein products; Advanced glycation end products
• Online Access: http://link.springer.com/article/10.1186/s12948-018-0099-2

Abstract Background Kounis syndrome (KS) has been described as the coincidental occurrence of acute coronary syndromes during an allergic reaction with cardiac anaphylaxis. It is caused by inflammatory mediators released after exposure to drugs, food, environmental and other triggers. Oxidative stress occurring in various inflammatory disorders causes molecular damage with the production of advanced oxidation products (AOPPs) and advanced glycation end products (AGEs). Case presentation Markers of oxidative stress were evaluated in a patient who had experienced KS after antibiotic administration in order to investigate the possible role of these molecules in KS. No data, up to now, are available on biomarkers of oxidative stress in patients with drug-induced KS. Conclusions AOPPs, but not AGEs, were significantly increased in the KS affected patient compared to controls as already reported in mastocytosis affected patients.